1. de Felice G, Hyland ME, Lanario JW, Antonacci Y, Jones RC, Masoli M. Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma. BMC Pulm Med 2021 Dec;21(1):1-8.
  2. Hyland, M.E., Lanario, J.W., Menzies-Gow, A., Mansur, A.H., Dodd, J.W., Fowler, S.J., Hayes, G., Jones, R.C. and Masoli, M., 2021. Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma. Chron Respir Dis, 18.
  3. Lanario JW, Burns L. Use of Health Related Quality of Life in Clinical Trials for Severe Asthma: A Systematic Review. J. Asthma Allergy. 2021;14:999.
  4. Masoli M, Lanario JW, Hyland ME, et al. The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference. Eur Respir J 2021; 57: 2100300.
  5. Lanario JW, Hyland ME, Menzies-Gow A, Mansur AH, Dodd JW, Fowler SJ, Jones RC, Masoli M. Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA). Health Qual. Life Outcomes. 2020 Dec.
  6. Lanario JW, Hyland ME, Wei Y, Jones RC, Masoli M. Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma. Respiratory Medicine. 2020 Jan 10:105870.
  7. Hyland ME, Lanario JW, Wei Y, Jones RC, Masoli M. Evidence for similarity in symptoms and mechanism: The extra‚Äźpulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia. Immunity, inflammation and disease. 2019 Aug 23.
  8. Hyland ME, Masoli M, Lanario JW, Jones RC. A possible explanation for non-responders, responders and super-responders to biologics in severe asthma. Exploratory Research and Hypothesis in Medicine. 2019 Jun 20;4(2):35-8.
  9. Hyland ME, Jones RC, Lanario JW, Masoli M. The construction and validation of the Severe Asthma Questionnaire. Eur Respir J. 2018 Jul 1;52(1).
  10. Hyland ME, Lanario JW, Pooler J, Masoli M, Jones RC. How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma. Health Qual. Life Outcomes. 2018 Dec;16(1):24.
  11. Jones RC, Masoli M, Lanario JW & Hyland ME 2017 'Improving quality of life relies on valid outcome measures as well as drugs' BMJ j4623-j4623.
  12. Hyland ME, Whalley B, Jones RC, Masoli M. A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales. Qual. Life Res. 2015 Mar 1;24(3):631-9.